Leveraging AI and Research Platforms to Accelerate Next-Generation Biological Modalities
As biologic modalities such as in vivo CAR therapies and antibody-drug conjugates (ADCs) rapidly advance, the need for efficient and scalable development solutions continues to grow. Join our webinar to explore how AI-enabled protein engineering, optimized reagents, and advanced assay platforms can support translational research, improve reproducibility, streamline manufacturing, and accelerate next-generation cancer therapeutics development...
